BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 18397706)

  • 1. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
    Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
    Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
    Namba T; Shiba R; Yamamoto T; Hirai Y; Moriwaki T; Matsuda J; Kadoya H; Takeji M; Yamada Y; Yoshihara H; Yamauchi A
    Clin Exp Nephrol; 2010 Aug; 14(4):372-6. PubMed ID: 20467773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.
    Sabry AA; Sobh MA; Sheaashaa HA; Kudesia G; Wild G; Fox S; Wagner BE; Irving WL; Grabowska A; El-Nahas AM
    Nephrol Dial Transplant; 2002 Nov; 17(11):1924-30. PubMed ID: 12401848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy.
    Wu H; Zou HB; Xu Y; Zhang L; Du YJ; Yu JY; Lu RH; Li X
    Am J Med Sci; 2013 Oct; 346(4):345-8. PubMed ID: 23744520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus.
    Lopes EP; Valente LM; Silva AE; Kirsztajn GM; Cruz CN; Ferraz ML
    Braz J Infect Dis; 2003 Oct; 7(5):353-7. PubMed ID: 14552746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pegylated interferon alpha-2a on hepatitis-C-virus-associated glomerulonephritis.
    Sugiura T; Yamada T; Kimpara Y; Fujita N; Goto K; Koyama N
    Pediatr Nephrol; 2009 Jan; 24(1):199-202. PubMed ID: 18696119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.
    Morales JM; Kamar N; Rostaing L
    Contrib Nephrol; 2012; 176():10-23. PubMed ID: 22310777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.
    Sarac E; Bastacky S; Johnson JP
    Am J Kidney Dis; 1997 Jul; 30(1):113-5. PubMed ID: 9214409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome.
    Nishi S; Ueno M; Shimada H; Oosawa Y; Iino N; Iguchi S; Karasawa R; In H; Kawashima S; Saito N; Imai N; Saito K; Suzuki S; Arakawa M; Gejyo F
    Intern Med; 2000 Oct; 39(10):788-93. PubMed ID: 11030201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of HCV-associated glomerulonephritis with pegylated ifn and ribavirin therapy after liver transplantation: case report and literature review.
    Donato MF; Fabrizi F; Fogazzi GB; Cresseri D; Passerini P; Martin P; Messa P
    Int J Artif Organs; 2013 Jan; 36(1):63-8. PubMed ID: 23280083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.
    Zeman M; Campbell P; Bain VG
    Can J Gastroenterol; 2006 Jun; 20(6):427-31. PubMed ID: 16779461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis.
    Suzuki T; Yonemura K; Miyaji T; Suzuki H; Takahira R; Fujigaki Y; Fujimoto T; Hishida A
    Intern Med; 2001 Aug; 40(8):708-12. PubMed ID: 11518107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiviral therapy on hepatitis C virus related glomerulopathy.
    Abbas G; Hussain S; Shafi T
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):775-80. PubMed ID: 18711294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
    Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.